focus -WSS

focus

author：hotspot 2025-10-02 23:31:40 - browse：31157

In a dark grey suit and light blue button-down shirt, Bill Sibold, CEO of Madrigal Pharmaceuticals, smiles— coverage from STAT — Madrigal CEO Bill Sibold says the company is "interested in the patients who are most in need." Madrigal Pharmaceuticals

The Food and Drug Administration is expected to approve the first medicine developed specifically to treat the serious liver disease known as MASH as soon as this week.

The pill, called resmetirom, is made by Madrigal Pharmaceuticals.

Metabolic dysfunction-associated steatohepatitis, or MASH and previously called NASH, is often associated with obesity. The accumulation of fat in the liver causes inflammation, which leads to fibrosis, or liver scarring, and can progress in more advanced stages to cirrhosis, cancer, and the need for a liver transplant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Neurocrine congenital adrenal hyperplasia trial succeeds

explore

WSS

Congress needs to close a vaccine

Senate bill would ban some hospital facility fees

For pregnant people, addiction treatment shouldn't mean a call to child protective services

David Liu startup to focus on CRISPR delivery

BD to buy Edwards patient monitoring unit for $4.2 billion

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

hotspot

focus

Wikipedia

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Elevance PBM president out as customers face prescription chaos

Virginia high school admissions case could be legal follow

Anthony Fauci pushes back on GOP claims during Covid hearing

Apple is now the first public company to be valued at $3 trillion

Grad students accuse University of California of wage theft

Novavax promises a turnaround & Lilly roils the obesity market

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Akili changes sales model for its ADHD video game treatment

focus

Covid’s new normal has set in amid another rise in cases

Medicare to pay more for cardiac rehab in hospital outpatient clinics

Eli Lilly’s Zepbound improved liver scarring in mid

How CO2 helps viruses stay alive longer in the air

David Liu startup to focus on CRISPR delivery

Medicare Advantage's lean provider networks lead CMS complaints

focus

explore

leisure time

knowledge